Gene expression profile in streptozotocin rat model for sporadic Alzheimer’s disease

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of neural transmission

• Publication date

  2004-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00702-003-0030-xPMID 14991460
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mitogen-activated protein kinase signaling.

  2004cited by this paper
• The GABAA Receptor α1 Subunit Pro174–Asp191 Segment Is Involved in GABA Binding and Channel Gating*

  2003cited by this paper
• Fluorescent multicolor multiplex homogeneous assay for the simultaneous analysis of the two most common hemochromatosis mutations.

  2002cited by this paper
• Coordinated patterns of gene expression for substrate and energy metabolism in skeletal muscle of diabetic mice

  2002influential reference
• mRNA expression alterations of inward rectifier potassium channels in rat brain with cholinergic impairment.

  2002cited by this paper
• Aberrant Expression of the Glutamate Transporter Excitatory Amino Acid Transporter 1 (EAAT1) in Alzheimer's Disease

  2002cited by this paper
• Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment.

  2002influential reference
• Does insulin dysfunction play a role in Alzheimer's disease?

  2002cited by this paper
• Differential expression of inflammation‐ and apoptosis‐related genes in spinal cords of a mutant SOD1 transgenic mouse 
model of familial amyotrophic lateral sclerosis

  2002cited by this paper
• Gene expression profiling of aging using DNA microarrays.

  2002cited by this paper
• Implications of circadian gene expression in kidney, liver and the effects of fasting on pharmacogenomic studies.

  2002cited by this paper
• Stimulation of β-Amyloid Precursor Protein Trafficking by Insulin Reduces Intraneuronal β-Amyloid and Requires Mitogen-Activated Protein Kinase Signaling

  2001cited by this paper
• Gene expression analysis in N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R‐apomorphine

  2001cited by this paper
• Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray.

  2001cited by this paper
• Application of DNA microarrays to study human alcoholism.

  2001cited by this paper
• Microarray profiling of gene expression in aging and its alteration by caloric restriction in mice.

  2001cited by this paper
• Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique.

  2001cited by this paper
• Sex, flies and microarrays

  2001cited by this paper
• β-amyloid peptide induces the expression of voltage dependent outward rectifying K+ channels in rat microglia

  2001cited by this paper
• Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment.

  2001cited by this paper
• Dopaminergic cell death induced by MPP+, oxidant and specific neurotoxicants shares the common molecular mechanism

  2001cited by this paper
• A Gene Expression Profile of Alzheimer's Disease

  2001cited by this paper
• Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia

  2001cited by this paper
• Genome-wide analysis of developmental and sex-regulated gene expression profiles in Caenorhabditis elegans.

  2001cited by this paper
• In vivo retinal gene expression in early diabetes.

  2001influential reference
• The glial glutamate transporter, GLT‐1, is oxidatively modified by 4‐hydroxy‐2‐nonenal in the Alzheimer's disease brain: the role of Aβ1–42

  2001cited by this paper
• Identification by mRNA Differential Display of Two Up-regulated Genes as Candidate Mediators of AIDS Dementia

  2001cited by this paper
• DNA microarray gene expression analysis technology and its application to neurological disorders

  2001cited by this paper
• Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis.

  2001influential reference
• The toxicology of aluminum in the brain: a review.

  2000cited by this paper
• Identifying a series of candidate genes for mania and psychosis: a convergent functional genomics approach.

  2000cited by this paper
• Insulin Effects on Glucose Metabolism, Memory, and Plasma Amyloid Precursor Protein in Alzheimer's Disease Differ According to Apolipoprotein‐E Genotype

  2000cited by this paper
• Rediscovering good old friend IGF-I in the new millenium: possible usefulness in Alzheimer's disease and stroke.

  2000cited by this paper
• Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants

  2000cited by this paper
• Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation.

  2000cited by this paper
• Gene expression in human alcoholism: microarray analysis of frontal cortex.

  2000cited by this paper
• Inhibition of the Neuronal Insulin Receptor An in Vivo Model for Sporadic Alzheimer Disease?

  2000cited by this paper
• EGR1 Target Genes in Prostate Carcinoma Cells Identified by Microarray Analysis*

  2000cited by this paper
• Potassium channels: molecular defects, diseases, and therapeutic opportunities.

  2000cited by this paper
• Density and pharmacology of alpha5 subunit-containing GABA(A) receptors are preserved in hippocampus of Alzheimer's disease patients.

  2000cited by this paper
• Genomics, gene expression and DNA arrays

  2000cited by this paper
• Insulin-like growth factor-1 (IGF-1): a neuroprotective trophic factor acting via the Akt kinase pathway.

  2000cited by this paper
• Molecular and Functional Diversity of the Expanding GABA‐A Receptor Gene Family

  1999cited by this paper
• A Disturbance in the Neuronal Insulin Receptor Signal Transduction in Sporadic Alzheimer's Disease

  1999cited by this paper
• Investigations on oxidative stress and therapeutical implications in dementia

  1999cited by this paper
• DNA microarrays in drug discovery and development

  1999cited by this paper
• The protective effect of K+ channel openers on beta-amyloid induced cerebrovascular endothelial dysfunction.

  1999cited by this paper
• High density synthetic oligonucleotide arrays

  1999cited by this paper
• Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761)

  1999influential reference
• Inhibition of the Neuronal Insulin Receptor Causes Alzheimer‐like Disturbances in Oxidative/Energy Brain Metabolism and in Behavior in Adult Rats

  1999cited by this paper
• Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content, GABA(A) receptor alpha-1 subunit messenger RNA and human GABA transporter-1 (HGAT-1) messenger RNA expression.

  1999cited by this paper
• Insulin Metabolism in Alzheimer’s Disease Differs According to Apolipoprotein E Genotype and Gender

  1999cited by this paper
• GABAA receptor β2 and β3 subunits mRNA in the hippocampal formation of aged human brain with Alzheimer-related neuropathology

  1998cited by this paper
• Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats.

  1998cited by this paper
• Alzheimer's disease – synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts

  1998cited by this paper
• Drug target validation and identification of secondary drug target effects using DNA microarrays

  1998cited by this paper
• Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease

  1998cited by this paper
• Risk factors for Alzheimer's disease during aging. Impacts of glucose/energy metabolism.

  1998cited by this paper
• Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis

  1998cited by this paper
• GABAA receptor beta 2 and beta 3 subunits mRNA in the hippocampal formation of aged human brain with Alzheimer-related neuropathology.

  1998cited by this paper
• Immunohistochemical study of GABAA receptor alpha1 subunit in the hippocampal formation of aged brains with Alzheimer-related neuropathologic changes.

  1998cited by this paper
• Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease

  1998cited by this paper
• Acetylcholine in human CSF: methodological considerations and levels in dementia of Alzheimer type

  1998cited by this paper
• Strong nuclear factor‐κB‐DNA binding parallels cyclooxygenase‐2 gene transcription in aging and in sporadic alzheimer's disease superior temporal lobe neocortex

  1998cited by this paper
• Free radicals in Alzheimer's dementia: currently available therapeutic strategies.

  1998cited by this paper
• Excitotoxicity and Oxidative Stress during Inhibition of Energy Metabolism

  1998cited by this paper
• Discovery and analysis of inflammatory disease-related genes using cDNA microarrays.

  1997cited by this paper
• Glutamate Transporter Alterations in Alzheimer Disease Are Possibly Associated with Abnormal APP Expression

  1997cited by this paper
• Diabetes-induced suppression of IGF-1 and its receptor mRNA levels in rat superior cervical ganglia.

  1997cited by this paper
• Models of Alzheimer's disease: cellular and molecular aspects.

  1997cited by this paper
• Insulin and Insulin-like Growth Factor-1 Regulate Tau Phosphorylation in Cultured Human Neurons*

  1997cited by this paper
• Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic alzheimer neocortex

  1997cited by this paper
• Glucose availability and the electrophysiology of the human visual system.

  1997cited by this paper
• Brain Glucose Metabolism Is Controlled by Amplification and Desensitization of the Neuronal Insulin Receptor a

  1996cited by this paper
• Oxidative-stress associated parameters (lactoferrin, superoxide dismutases) in serum of patients with Alzheimer's disease.

  1996cited by this paper
• The neurochemistry of Alzheimer type, vascular type and mixed type dementias compared.

  1996cited by this paper
• Use of a cDNA microarray to analyse gene expression patterns in human cancer

  1996cited by this paper
• A rapid protocol for isolation of RNA from mycobacteria

  1995cited by this paper
• Insulin-like growth factor-I receptor densities in human frontal cortex and white matter during aging, in Alzheimer's disease, and in Huntington's disease.

  1994cited by this paper
• Behavioral and biochemical effects of an ICV injection of streptozotocin in old Lewis rats.

  1994cited by this paper
• Long‐Term Diabetogenic Effect of Streptozotocin in Rats

  1993cited by this paper
• Spatial learning deficit and reduced hippocampal ChAT activity in rats after an ICV injection of streptozotocin.

  1993cited by this paper
• Glycogen synthase kinase‐3 and the Alzheimer‐like state of microtubule‐associated protein tau

  1992cited by this paper
• Insulin differentially regulates protein phosphotyrosine phosphatase activity in rat hepatoma cells.

  1992cited by this paper
• Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex.

  1991cited by this paper
• Differential Effects of Diabetes on Adipocyte and Liver Phosphotyrosine and Phosphoserine Phosphatase Activities

  1991cited by this paper
• A method for isolation of RNA from Pneumocystis carinii.

  1989cited by this paper
• Giardia lamblia: isolation of RNA.

  1989cited by this paper
• Hepatic phosphotyrosine phosphatase activity and its alterations in diabetic rats.

  1989cited by this paper
• Isolation and in vitro translation of Onchocerca volvulus mRNA.

  1988cited by this paper
• Diabetes-induced functional and structural changes in insulin receptors from rat skeletal muscle.

  1986cited by this paper
• Neurotransmitters in the brains of patients with dementia disorders.

  1985cited by this paper
• Neurotransmitters in the brains of patients with dementia disorders.

  1985cited by this paper
• Decreased autophosphorylation of the insulin receptor-kinase in streptozotocin-diabetic rats.

  1984cited by this paper

• Approaching therapy of Alzheimer’s disease via the antidiabetic drug liraglutide—a study with streptozotocin intracerebroventricularly treated Wistar rats

  2025cites this paper
• Glutamate stress in the caudal nucleus tractus solitarii (nTS): Impact on respiratory function and synaptic signaling in an Alzheimer's disease model.

  2025cites this paper
• Central Insulin-like Growth Factor-1 Treatment Enhances Working and Reference Memory by Reducing Neuroinflammation and Amyloid Beta Deposition in a Rat Model of Sporadic Alzheimer’s Disease

  2025cites this paper
• Proteomic Analysis of a Rat Streptozotocin Model Shows Dysregulated Biological Pathways Implicated in Alzheimer’s Disease

  2024cites this paper
• Investigating the Impact of Intracerebroventricular Streptozotocin on Female Rats with and without Ovaries: Implications for Alzheimer’s Disease

  2024cites this paper
• Cучасні підходи до моделювання когнітивних порушень в експерименті (огляд літератури) Current modeling approaches to experimental cognitive impairment

  2022cites this paper
• Tau Cleavage Contributes to Cognitive Dysfunction in Strepto-Zotocin-Induced Sporadic Alzheimer’s Disease (sAD) Mouse Model

  2021cites this paper
• Insulin‐like growth factor 1 gene transfer for sporadic Alzheimer's disease: New evidence for trophic factor mediated hippocampal neuronal and synaptic recovery‐based behavior improvement

  2021cites this paper
• Decreased excitability of locus coeruleus neurons during hypercapnia is exaggerated in the streptozotocin-model of Alzheimer's disease.

  2020cites this paper
• Hypercapnic and Hypoxic Respiratory Response During Wakefulness and Sleep in a Streptozotocin Model of Alzheimer’s Disease in Rats

  2018cites this paper
• The Effects of Melilotus officinalis Extract on Expression of Daxx, Nfkb and Vegf Genes in the Streptozotocin-Induced Rat Model of Sporadic Alzheimer’s Disease

  2017cites this paper
• Effects of Ectoine on Behavior and Candidate Genes Expression in ICV-STZ Rat Model of Sporadic Alzheimer’s Disease

  2017cites this paper
• NADPH oxidase contributes to streptozotocin-induced neurodegeneration.

  2017cites this paper
• Mitochondrial protective and anti-apoptotic effects of Rhodiola crenulata extract on hippocampal neurons in a rat model of Alzheimer's disease

  2017cites this paper
• Behavioral effect of phosphatidylcholine isolated from soy lecithin in streptozotocin induced experimental alzheimers model

  2017cites this paper
• Brain insulin signaling in Alzheimer's disease

  2017cites this paper
• Intracerebroventricular Streptozotocin as a Model of Alzheimer’s Disease: Neurochemical and Behavioral Characterization in Mice

  2016cites this paper
• Animal Models in Drug Discovery of Alzheimer’s Disease: A Mini Review

  2016influential citation
• A Review of Animal Models of Alzheimer's Disease: a brief insight to Pharmacologic and genetic models

  2016cites this paper
• Targeting Alzheimer’s Disease Neuro-Metabolic Dysfunction with a Small Molecule Nuclear Receptor Agonist (T3D-959) Reverses Disease Pathologies

  2016cites this paper
• Quantitative Expression Analysis of APP Pathway and Tau Phosphorylation-Related Genes in the ICV STZ-Induced Non-Human Primate Model of Sporadic Alzheimer’s Disease

  2015cites this paper
• Animal models of Alzheimer disease: historical pitfalls and a path forward.

  2014cites this paper
• Animal models of dementia and cognitive dysfunction.

  2014cites this paper
• Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms.

  2013cites this paper
• Brain Insulin Dysregulation: Implication for Neurological and Neuropsychiatric Disorders

  2013cites this paper
• Modeling Alzheimer's disease with non-transgenic rat models

  2013cites this paper
• Hypoglycemia induces tau hyperphosphorylation.

  2013cites this paper
• What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer’s disease, about the therapeutic strategies in Alzheimer’s research

  2012cites this paper
• Different approaches, one target: understanding cellular mechanisms of Parkinson's and Alzheimer's diseases.

  2012cites this paper
• Beta-Amyloid Monomer and Insulin/IGF-1 Signaling in Alzheimer's Disease

  2012cites this paper
• The effect of saffranal on intracerebroventricular strepto- zotocin-induced cognitive deficits in rat

  2012cites this paper
• Striatal dopamine receptors modulate the expression of insulin receptor, IGF-1 and GLUT-3 in diabetic rats: effect of pyridoxine treatment.

  2012cites this paper
• Transcriptional alterations under continuous or pulsatile dopaminergic treatment in dyskinetic rats

  2011cites this paper
• The link between iron, metabolic syndrome, and Alzheimer’s disease

  2011cites this paper
• Diabetes Type II: A Risk Factor for Depression–Parkinson–Alzheimer?

  2011cites this paper
• EXPERIMENTAL MODELS FOR ALZHEIMER’S DISEASE: A MECHANISTIC VIEW

  2010cites this paper
• Uncovering Molecular Biomarkers That Correlate Cognitive Decline with the Changes of Hippocampus' Gene Expression Profiles in Alzheimer's Disease

  2010cites this paper
• Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins.

  2009cites this paper
• The Effect of Aqueous Crocus sativus L. Extract on Intracerebroventricular Streptozotocin-induced Cognitive Deficits in Rat: a Behavioral Analysis

  2009cites this paper
• Insulin signaling and synaptic physiology: Insights into the pathogenesis of Alzheimer's disease

  2009cites this paper
• Mefenamic Acid Attenuates Intracerebroventricular Streptozotocin-Induced Cognitive Deficits in the Rat: A Behavioral Analysis

  2007cites this paper
• Long-term abnormalities in brain glucose/energy metabolism after inhibition of the neuronal insulin receptor: implication of tau-protein.

  2007cites this paper
• Streptozotocin-induced diabetes is associated with changes in NGF levels in pancreas and brain.

  2007cites this paper
• Therapeutic targets and potential of the novel brain‐ permeable multifunctional iron chelator–monoamine oxidase inhibitor drug, M‐30, for the treatment of Alzheimer's disease 1

  2007cites this paper
• Comparison Analysis of Gene Expression Patterns between Sporadic Alzheimer's and Parkinson's Disease

  2007cites this paper
• Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach.

  2007influential citation
• Genomics and proteomics are changing discovery, development and clinical use of dementia drugs

  2007cites this paper
• S100B content and secretion decrease in astrocytes cultured in high-glucose medium.

  2007cites this paper
• Dementia: The Significance of Cerebral Metabolic Disturbances in Alzheimer's Disease. Relation to Parkinson's Disease

  2007cites this paper
• Alterations in Expression of Glutamatergic Transporters and Receptors in Sporadic Alzheimer's Disease

  2007cites this paper
• Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein

  2007cites this paper
• Gene expression alterations in brain areas of intracerebroventricular streptozotocin treated rat

  2006influential citation
• Neuroactive steroids prevent peripheral myelin alterations induced by diabetes.

  2006cites this paper
• Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models.

  2006cites this paper
• Avaliação de Parâmetros Bioquímicos e Morfológicos de Células Gliais Expostas a um Meio com Alto Conteúdo de Glicose

  2006cites this paper
• Effect of Naringenin on Intracerebroventricular Streptozotocin-Induced Cognitive Deficits in Rat: A Behavioral Analysis

  2006cites this paper
• Expression of chaperonin 60 in the hippocampus of the streptozotocin diabetic rat

  2006cites this paper
• Cerebrovascular damage as a cause for Alzheimer's disease.

  2005cites this paper
• Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives.

  2005cites this paper
• Diagnosis and treatment of Alzheimer’s disease

  2005cites this paper
• Insulin-Degrading Enzyme as a Downstream Target of Insulin Receptor Signaling Cascade: Implications for Alzheimer's Disease Intervention

  2004cites this paper